Further research targeting the broader circadian molecular machinery, including genes like BMAL1, PER, CRY, and REV-ERB, may provide deeper insights into how circadian regulation affects metabolic diseases such as insulin resistance, diabetes, and obesity. This evidence concerns the gene CRYL1 and diabetes mellitus.